ELV | Elevance Health Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31
Revenue	171.34B	156.59B	138.64B	121.87B	104.21B	92.11B	90.04B	84.86B	79.16B	73.87B	71.02B	61.71B	60.71B	58.80B	65.03B	61.25B	61.13B	56.95B	45.14B	20.82B	16.77B	13.28B	10.44B	17.31B	12.35B	11.07B
Cost of Revenue	17.29B	13.04B	10.89B	8.95B	1.99B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	154.05B	143.56B	127.74B	112.91B	102.22B	92.11B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Expenses	38.27B	17.69B	15.91B	-126.01B	-98.23B	-86.28B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Admin	36.45B	17.69B	15.91B	17.45B	13.36B	14.02B	12.65B	12.56B	12.53B	11.75B	9.95B	8.74B	8.44B	8.84B	9.66B	9.02B	8.70B	8.82B	7.27B	3.48B	3.11B	2.51B	1.99B	N/A	N/A	N/A
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Operating Expenses	38.27B	-31.45B	-27.05B	-26.11B	-15.69B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-4.00M	7.77B	7.92B	6.24B	5.99B	5.07B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Expenses / Income	7.71B	-851.00M	12.65B	10.38B	-82.87B	-753.00M	33.10M	35.10M	43.10M	41.30M	40.40M	297.70M	41.00M	36.50M	7.79B	4.48B	5.27B	4.98B	3.92B	2.04B	1.60B	1.34B	1.20B	N/A	N/A	N/A
Before Tax Income	7.71B	7.77B	7.92B	6.24B	5.99B	5.07B	3.96B	4.56B	4.63B	4.37B	3.84B	3.87B	3.96B	4.35B	7.40B	3.12B	5.26B	4.91B	3.89B	1.44B	1.22B	807.60M	524.60M	N/A	N/A	N/A
Income Tax Expenses	1.72B	1.75B	1.83B	1.67B	1.18B	1.32B	121.00M	2.09B	2.07B	1.81B	1.21B	1.21B	1.31B	1.47B	2.66B	631.70M	1.91B	1.82B	1.43B	483.20M	440.10M	255.20M	183.40M	N/A	N/A	N/A
Net Income	5.99B	5.89B	6.16B	4.57B	4.81B	3.75B	3.84B	2.47B	2.56B	2.57B	2.49B	2.66B	2.65B	2.89B	4.75B	2.49B	3.35B	3.09B	2.46B	960.10M	774.30M	549.10M	342.20M	226.00M	44.90M	172.40M
Interest Expenses	1.03B	851.00M	798.00M	784.00M	746.00M	753.00M	739.00M	723.00M	653.00M	600.70M	602.70M	511.80M	430.30M	418.90M	447.40M	469.80M	447.90M	403.50M	226.20M	142.30M	131.20M	98.50M	60.20M	N/A	N/A	N/A
Basic Shares Outstanding	235.90M	240.00M	243.80M	250.80M	255.50M	250.80M	256.08M	263.75M	261.24M	268.11M	293.27M	304.72M	339.37M	377.74M	483.20M	524.30M	593.16M	627.77M	611.36M	276.51M	276.54M	238.22M	206.77M	206.18M	206.18M	206.18M
Diluted Shares Outstanding	237.40M	242.80M	246.80M	254.30M	260.30M	254.30M	267.80M	268.10M	272.90M	285.90M	303.80M	324.80M	365.10M	415.80M	483.20M	524.30M	601.69M	642.10M	625.33M	285.67M	284.15M	243.50M	207.39M	206.18M	206.18M	206.18M
EBITDA	1.74B	9.44B	9.23B	7.39B	7.12B	6.20B	5.59B	6.19B	6.19B	5.83B	5.21B	5.12B	5.03B	5.37B	7.96B	3.70B	6.29B	5.92B	4.75B	1.86B	1.59B	1.06B	706.30M	226.00M	44.90M	172.40M
EBITDA Margin	1.02%	6.03%	6.66%	6.07%	6.83%	6.73%	6.21%	7.29%	7.82%	7.89%	7.33%	8.29%	8.28%	9.14%	12.24%	6.04%	10.29%	10.40%	10.52%	8.96%	9.48%	7.98%	6.76%	1.31%	0.36%	1.56%
EBIT	8.74B	8.49B	8.79B	7.02B	6.73B	5.82B	4.70B	5.28B	5.28B	4.98B	4.30B	4.38B	4.39B	4.77B	7.85B	3.59B	5.71B	5.32B	4.12B	1.59B	1.35B	902.80M	585.80M	226.00M	44.90M	172.40M
EBIT Margin	5.10%	5.42%	6.34%	5.76%	6.46%	6.32%	5.22%	6.22%	6.68%	6.74%	6.05%	7.09%	7.23%	8.12%	12.07%	5.86%	9.33%	9.34%	9.12%	7.62%	8.02%	6.80%	5.61%	1.31%	0.36%	1.56%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31